Previous studies have shown that increased parathyroid hormone (PTH) attributable to
secondary hyperparathyroidism in chronic kidney disease accelerates the arteriosclerotic …

Until recently, transcatheter aortic valve implantation was restricted to high-risk and
inoperable patients. The updated 2017 European Society of Cardiology Guidelines has …

Background Menopause is associated with an increased risk for osteoporosis (OP) and
coronary artery disease (CAD). The goal of this study was to seek the possible relationship …

The purpose of this study was to test the hypothesis that an experimental high fat (HF)
animal with metabolic syndrome results in structural degeneration of the aortic valve …

Aortic valve calcification can aggravate aortic stenoses, and it is a significant cause of
sudden cardiac death. The increasing number of patients with age-related calcification is a …

Current development of nano/microscale modification technology of Ti-based implants was
focused on the acceleration of ossification and consequent reduction of immunological …

Atherosclerosis and calcific aortic valve disease (CAVD) are two distinct, morbid processes
that share similar pathophysiological events. Both diseases are characterized by recruitment …

Background Aortic stenosis (AS) is the most common valvular disease. Endothelial
progenitor cells (EPCs) have a role in the repair of endothelial surfaces after injury. Reduced …

The aim of this study was to characterize endothelial progenitor cells with osteoblastic
phenotype (EPC-OCNs) and their role in individuals with varying degrees of aortic stenosis …

Heterozygous familial hypercholesterolemia (heFH) is an autosomal dominant lipid
metabolism disorder. Its prevalence is 1: 250–1: 30 0 people in the population. Patients with …